Speaker illustration

Doctor Radoslaw Piatkowski

Medical University of Warsaw, Warsaw (Poland)

Member of:

Heart Failure Association

Right ventricular dysfunction in patients with non-severe ischemic mitral regurgitation qualified to cardiosurgery treatment.

Event: EuroEcho 2021

Topic: Systolic and Diastolic Function

Session: e-posters session - Echocardiography

Thumbnail

Stress echocardiography in patients with ischemic mitral regurgitation and left ventricular dysfunction qualified to cardiosurgery treatment.

Event: EuroEcho 2021

Topic: Valvular Heart Disease

Session: e-posters session - Echocardiography

Thumbnail

Impact of exercise on platelet activity in patients with significant ischemic mitral regurgitation qualified for cardiosurgery treatment

Event: EuroEcho 2019

Topic: Stress Echocardiography

Session: Stress Echocardiography

Thumbnail

Late recovery of left ventricular function in patients with non-severe ischemic mitral regurgitation and multivessel disease qualified to cardiosurgery treatment.

Event: EuroEcho 2019

Topic: Imaging of Systolic and Diastolic Function

Session: Imaging: Systolic and Diastolic Function

Thumbnail

Inadequate inhibition of platelet function after exercise in patients with ischemic mitral regurgitation qualified for cardiosurgery treatment

Event: EuroEcho 2019

Topic: Stress Echocardiography

Session: Stress Echocardiography

Thumbnail

Long-term prognosis of patients with non-severe ischemic mitral regurgitation undergoing coronary artery bypass grafting

Event: EuroEcho-Imaging 2018

Topic: Valvular Heart Disease

Session: Echocardiography: Valve Disease

Thumbnail

The prognostic importance of mitral deformation indexes and left ventricle volumes in patients with ischemic mitral regurgitation and multivessel disease qualified to cardiosurgery treatment

Event: EuroEcho-Imaging 2018

Topic: Valvular Heart Disease

Session: Echocardiography: Valve Disease

Thumbnail

This platform is supported by

logo Novo Nordisk